Browse by Medical Category
Accepting New Patients
Amy Yule, MD is the medical director of the Addiction Recovery Management Service where she works with youth with substance use disorders and co-occurring psychiatric illness.
Go To Programs
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Yule received her undergraduate degree from the University of California San Diego. She attended the David Geffen School of Medicine at University of California Los Angeles. Dr. Yule completed her adult and child psychiatry training at Massachusetts General Hospital and McLean Hospital. She completed her addiction psychiatry training in the Partners Hospital program. She is the medical director of the Addiction Recovery Management Service at Massachusetts General Hospital where she works with youth ages 14 to 26 with substance use disorders and co-occurring psychiatric illness and their families. She is also an instructor in psychiatry at Harvard Medical School.
In addition to providing clinical care Dr. Yule is involved in clinical research. She has been the recipient of grant funding from the American Academy of Child and Adolescent Psychiatry, the Massachusetts General Hospital Louis V. Gerstner research scholar award, and the National Institute of Drug Abuse. Her research interests include the investigation of risk factors for adolescent onset substance use disorders, risk factors associated with risky behaviors in youth with substance use disorders such as overdose, and the impact of medication treatment for youth with substance use disorders and co-occurring psychiatric illness. She is currently the primary investigator for a study evaluating the effect of treatment with quetiapine (seroquel) for youth with a substance use disorder and bipolar disorder.
View my most recent research
Dr. Yule is currently recruiting subjects for a clinical trial evaluating the effect of treatment with quetiapine (seroquel) on substance use and mood for youth with a substance use disorder and bipolar disorder.
Research at the MGH is interwoven throughout more than 30 departments, centers and units and is conducted with the support and guidance of the MGH Research Institute. The Research Roundup is a monthly series highlighting studies, news and events.
A team of Massachusetts General Hospital investigators has identified factors that may increase the risk of drug overdose in adolescents and young adults.
Back to Top